Ryan Stuchbery

89 Bridge Road
Richmond, VIC 3121, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

The Germline and Somatic Origins of Prostate Cancer Heterogeneity.

The Germline and Somatic Origins of Prostate Cancer Heterogeneity.

Journal: Cancer discovery

Published: August 03, 2023

Transcriptome sequencing and multi-plex imaging of prostate cancer microenvironment reveals a dominant role for monocytic cells in progression.

Transcriptome sequencing and multi-plex imaging of prostate cancer microenvironment reveals a dominant role for monocytic cells in progression.

Journal: BMC cancer

Published: March 10, 2021

Loss of SNAI2 in Prostate Cancer Correlates With Clinical Response to Androgen Deprivation Therapy.

Loss of SNAI2 in Prostate Cancer Correlates With Clinical Response to Androgen Deprivation Therapy.

Journal: JCO precision oncology

Published: August 20, 2020

MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancer.

MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancer.

Journal: Prostate cancer and prostatic diseases

Published: July 27, 2020

Androgen deprivation therapy promotes an obesity-like microenvironment in periprostatic fat.

Androgen deprivation therapy promotes an obesity-like microenvironment in periprostatic fat.

Journal: Endocrine connections

Published: March 14, 2019

Late biochemical recurrence after radical prostatectomy is associated with a slower rate of progression.

Late biochemical recurrence after radical prostatectomy is associated with a slower rate of progression.

Journal: BJU international

Published: September 25, 2018

Developments in oligometastatic hormone-sensitive prostate cancer.

Developments in oligometastatic hormone-sensitive prostate cancer.

Journal: World journal of urology

Published: July 17, 2018

Periprostatic fat tissue transcriptome reveals a signature diagnostic for high-risk prostate cancer.

Periprostatic fat tissue transcriptome reveals a signature diagnostic for high-risk prostate cancer.

Journal: Endocrine-related cancer

Published: March 17, 2018

Androgen synthesis in prostate cancer: do all roads lead to Rome?

Androgen synthesis in prostate cancer: do all roads lead to Rome?

Journal: Nature reviews. Urology

Published: November 09, 2016

Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progression.

Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progression.

Journal: Oncotarget

Published: October 18, 2015

Molecular Pathways: Targeting DNA Repair Pathway Defects Enriched in Metastasis.

Molecular Pathways: Targeting DNA Repair Pathway Defects Enriched in Metastasis.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 02, 2015

Target Acquired: Progress and Promise of Targeted Therapeutics in the Treatment of Prostate Cancer.

Target Acquired: Progress and Promise of Targeted Therapeutics in the Treatment of Prostate Cancer.

Journal: Current cancer drug targets

Published: November 30, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026